You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
屈臣氏延續與ChromaDex合作夥伴關係 獨家發售保健品TRU NIAGEN
阿思達克 08-26 16:01
屈臣氏宣布,自2017年推出保健品「樂加欣」(TRU NIAGEN)以來已售出超過130萬瓶,未來三年將與ChromaDex延續獨家合作夥伴關係。 屈臣氏表示,去年與ChromaDex再度合作於香港推出全球首個NIAGEN美容保健產品TRU NIAGEN Beauty,銷售錄得按年增長逾60%,現時於新加坡屈臣氏發售。 屈臣氏集團(亞洲及歐洲)行政總裁倪文玲表示,全球疫情促使更多顧客選購膳食補充劑以保持健康,因此產品需求在過去一年激增,對於與ChromaDex延續獨家合作夥伴關係感到十分高興。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account